RE: Comparative effectiveness of neoadjuvant therapy for HER2-positive breast cancer: a network meta-analysis

Xiaolong Qi1, Li-Juan Ji1, Xiaoshen Zhang1

  • 1Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China (XQ, WM); Tongji University School of Medicine, Shanghai, China (XQ, XZ); Department of Rehabilitation, the Second People's Hospital of Huai'an, Huai'an, China (LJJ); Department of Internal Medicine, Cangzhou Central Hospital, Cangzhou,China (YM).

Abstract

No abstract available in PubMed .

Related Concept Videos